X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (58) 58
human necessities (58) 58
hygiene (58) 58
medical or veterinary science (58) 58
metallurgy (58) 58
organic chemistry (58) 58
peptides (58) 58
preparations for medical, dental, or toilet purposes (58) 58
humans (52) 52
microbiology (49) 49
beer (47) 47
biochemistry (47) 47
enzymology (47) 47
mutation or genetic engineering (47) 47
spirits (47) 47
vinegar (47) 47
wine (47) 47
specific therapeutic activity of chemical compounds ormedicinal preparations (46) 46
compositions thereof (43) 43
culture media (43) 43
microorganisms or enzymes (43) 43
propagating, preserving or maintaining microorganisms (43) 43
immunology (33) 33
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (31) 31
male (31) 31
transplantation (29) 29
female (25) 25
animals (24) 24
surgery (23) 23
adult (18) 18
index medicus (18) 18
middle aged (18) 18
child (14) 14
processes using microorganisms (13) 13
adolescent (12) 12
child, preschool (12) 12
liver transplantation - immunology (12) 12
rejection (12) 12
graft rejection - immunology (11) 11
rats (11) 11
antibodies, monoclonal - pharmacology (9) 9
mice (9) 9
organ-transplantation (9) 9
cd2 antigens - immunology (8) 8
graft rejection (8) 8
graft survival (8) 8
immunosuppressive agents - therapeutic use (8) 8
recipients (8) 8
aged (7) 7
cells, cultured (7) 7
graft rejection - prevention & control (7) 7
immunosuppression (7) 7
infant (7) 7
kidney transplantation - immunology (7) 7
liver transplantation (7) 7
treatment outcome (7) 7
antibodies, monoclonal - therapeutic use (6) 6
in-vitro (6) 6
liver (6) 6
prognosis (6) 6
t-lymphocytes - immunology (6) 6
tolerance (6) 6
transplantation, heterologous - immunology (6) 6
allograft-rejection (5) 5
diagnosis (5) 5
disease (5) 5
immunosuppressive agents - administration & dosage (5) 5
immunosuppressive agents - pharmacology (5) 5
kidney transplantation (5) 5
medical laboratory technology (5) 5
prospective studies (5) 5
survival (5) 5
swine (5) 5
tacrolimus (5) 5
tacrolimus - therapeutic use (5) 5
young adult (5) 5
acute rejection (4) 4
allergy and immunology (4) 4
antibodies (4) 4
cells (4) 4
dose-response relationship, drug (4) 4
endothelium, vascular - immunology (4) 4
gastroenterology & hepatology (4) 4
gene-expression (4) 4
graft survival - immunology (4) 4
hematology (4) 4
liver transplantation - methods (4) 4
liver-transplantation (4) 4
lymphocyte culture test, mixed (4) 4
mice, scid (4) 4
monitoring, immunologic - methods (4) 4
pediatrics (4) 4
retrospective studies (4) 4
t-cells (4) 4
therapy (4) 4
time factors (4) 4
ulcerative colitis (4) 4
xenotransplantation (4) 4
abridged index medicus (3) 3
acute lymphoblastic-leukemia (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Pharmacogenomics, ISSN 1462-2416, 05/2010, Volume 11, Issue 5, pp. 703 - 714
Journal Article
BMC Research Notes, ISSN 1756-0500, 01/2017, Volume 10, Issue 1, pp. 1 - 4
Neutrophil-to-lymphocyte ratio (NLR) has proven its prognostic value in cardiovascular diseases, infections, inflammatory diseases and in several types of... 
Cells count | Laboratory testing | Neutrophil-to-lymphocyte ratio | Reference values | Neutrophils - cytology | Prognosis | Humans | Middle Aged | Male | Reference Values | Inflammation | Lymphocytes - cytology | Healthy Volunteers | Young Adult | Lymphocyte Count | Adult | Female | Aged
Journal Article
Haematologica, ISSN 0390-6078, 07/2012, Volume 97, Issue 7, pp. 1064 - 1072
Background ETV6-PDGFRB (also called TEL-PDGFRB) and FIP1L1-PDGFRA are receptor-tyrosine kinase fusion genes that cause chronic myeloid malignancies associated... 
PDGF receptor | Signal transduction | Hematopoietic progenitors | Tyrosine kinase inhibitors | Myeloproliferative neoplasms | Eosinophils | myeloproliferative neoplasms | FUSION | signal transduction | TEL-PDGFR-BETA | CONSTITUTIVE ACTIVATION | TEL/PDGF-BETA-R | eosinophils | tyrosine kinase inhibitors | IN-VITRO | hematopoietic progenitors | GENE | GROWTH | HYPEREOSINOPHILIC SYNDROME | SMOOTH-MUSCLE-CELLS | HEMATOLOGY | CHRONIC MYELOMONOCYTIC LEUKEMIA | Eosinophilia - metabolism | Eosinophils - metabolism | Oncogene Proteins, Fusion - metabolism | Antigens, CD34 - metabolism | Eosinophils - drug effects | Gene Expression - drug effects | mRNA Cleavage and Polyadenylation Factors - metabolism | Humans | STAT Transcription Factors - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | NF-kappa B - metabolism | Eosinophilia - pathology | I-kappa B Kinase - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Eosinophilia - genetics | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications | Transgenes | mRNA Cleavage and Polyadenylation Factors - genetics | Hematopoietic Stem Cells - drug effects | Receptor, Platelet-Derived Growth Factor alpha - metabolism | Transduction, Genetic | Cells, Cultured | Hematopoietic Stem Cells - metabolism | I-kappa B Kinase - genetics | STAT Transcription Factors - genetics | NF-kappa B - genetics | Signal Transduction - drug effects | Cell Differentiation - drug effects | Oncogene Proteins, Fusion - genetics | Receptor, Platelet-Derived Growth Factor alpha - genetics | Hematopoietic Stem Cells - cytology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Cell Proliferation - drug effects | Eosinophilia - complications | Protein Kinase Inhibitors - pharmacology | Eosinophils - cytology | Antigens, CD34 - genetics | Fetal Blood | Original and Brief Reports
Journal Article
Annals of Surgery, ISSN 0003-4932, 12/2015, Volume 262, Issue 6, pp. 1141 - 1149
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2010, Volume 116, Issue 21, pp. 1121 - 1121
Abstract Abstract 1121 Introduction: D variant is a common phenotype in Africans. However, the allele multiplicity challenges the serological methods which... 
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2012, Volume 156, Issue 1, pp. 76 - 88
Summary The PRDM16 (1p36) gene is rearranged in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) with t(1;3)(p36;q21), sharing characteristics... 
myelodysplastic syndrome | 1p36 | acute myeloid leukaemia | lymphoid malignancy | PRDM16 | Acute myeloid leukaemia | Lymphoid malignancy | Myelodysplastic syndrome | CELLS | BONE-MARROW | IDENTIFICATION | TRANSCRIPTS | ACUTE LYMPHOBLASTIC-LEUKEMIA | RUNX1-PRDM16 FUSION | GENE-EXPRESSION | MEL1 | PATIENT | HEMATOLOGY | T(1/3)(P36,Q21) | Translocation, Genetic | Prognosis | Chromosome Breakpoints | Humans | Middle Aged | Child, Preschool | Male | Young Adult | Chromosomes, Human, Pair 1 | Base Sequence | Aged, 80 and over | Adult | Female | Child | Gene Order | Chromosome Banding | Kaplan-Meier Estimate | Lymphoma - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Leukemia, Myeloid, Acute - mortality | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Oncogene Proteins, Fusion - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Adolescent | Myelodysplastic Syndromes - mortality | Aged | Myelodysplastic Syndromes - genetics | Leukemia, Myeloid, Acute - genetics | Fluorescence | DNA binding proteins | Leukemia | Genes | Medical genetics | CD34 antigen | Translocation | Breakpoints | Transcription factors | Karyotypes | Data processing | Malignancy | Survival | Chromosome 1 | Promoters | Polymerase chain reaction | Chromosome translocations | Fluorescence in situ hybridization | chromosome 3 | Bone marrow | gene rearrangement | Fusion protein | Age
Journal Article